Vertex Inc.
VERX | NASDAQ
$12.08
+$0.12 (+1.00%)
At close: Sep 21, 2026, 4:00 PM ET
$12.21
+$0.13 (+1.08%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Company Profile
Vertex, Inc. specializes in delivering advanced tax technology solutions to corporations across various sectors, including retail, communication, leasing, and manufacturing. These services are provided to clients both within the United States and globally. Its comprehensive product portfolio encompasses tools for tax determination, compliance and reporting, efficient tax data and document management, pre-built integration capabilities, and specialized solutions tailored to specific industries. Clients can access their software through traditional on-premise licenses or via cloud-based Software as a Service (SaaS) subscriptions. Beyond its software offerings, Vertex also delivers essential support services. These include implementation and training for its licensed and cloud-based products, as well as outsourced transaction tax return processing and other ancillary tax-related consultations. Established in 1978, Vertex, Inc. has its headquarters situated in King of Prussia, Pennsylvania.
Key Executives
| Name | Position |
|---|---|
| Christopher David Young | Chief Executive Officer, President & Director |
| John R. Schwab | Chief Financial Officer |
| Salvatore Visca | Chief Technology Officer |
| Amanda Westphal Radcliffe | Co-Owner & Independent Director |
| Aneel Jaeel | Chief Operations Officer |
| Bala Chandran | Chief Product & Technology Officer |
| Bryan T. R. Rowland | Senior Vice President, General Counsel & Secretary |
| Joseph J. Crivelli | Vice President of Investor Relations |
| Ray Westphal | Founder |
| Ryan J. Leib | Chief Accounting Officer |
| Stefanie Westphal-Lucas Thompson | Co-Owner & Independent Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 04, 2026 | 10-Q | Quarterly Report |
| Aug 03, 2026 | 8-K | Current Report |
| Jun 12, 2026 | 4 | Filing |
| Jun 12, 2026 | 4 | Filing |
| Jun 12, 2026 | 4 | Filing |
| Jun 12, 2026 | 4 | Filing |
| Jun 12, 2026 | 4 | Filing |
| Jun 12, 2026 | 4 | Filing |
| Jun 12, 2026 | 4 | Filing |
| Jun 12, 2026 | 4 | Filing |
Vertex Inc.
| Country | United States |
| IPO Date | Jul 28, 2020 |
| Industry | Software - Application |
| Sector | Technology |
| Employees | 2,000 |
| CEO | Christopher David Young |
Contact Details
2301 Renaissance Boulevard King of Prussia,
Pennsylvania 19406 United States
Stock Details
| Ticker Symbol | VERX |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001806837 |
| CUSIP Number | 92538J106 |
| ISIN Number | US92538J1060 |
| SIC Code | 7372 |
Recent News
- 8 days ago / marketbeat.comVertex Pharmaceuticals Eyes Renal Growth With Key PDUFA, Pipeline Catalysts Ahead
- 11 days ago / fxempire.comStrong Core Business, Raised Guidance Push Vertex Pharmaceuticals Higher
- 13 days ago / seekingalpha.comVertex, Inc. (VERX) Presents at Goldman Sachs Communacopia + Technology Conference 2026 Transcript
- 14 days ago / fool.comGoldman Sachs Just Added Vertex Pharmaceuticals to Its Conviction List. Here's the Bull Case for the Big Biotech Stock
- 18 days ago / fool.comVertex vs. Regeneron: Which Biotech Giant Is the Better Buy Right Now?
- 21 days ago / businesswire.comVertex Completes Acquisition of Crinetics Pharmaceuticals and Announces Expansion of Executive Leadership Team
- 27 days ago / businesswire.comVertex to Participate in Upcoming September Investor Conferences
- 27 days ago / zacks.comVertex Pharmaceuticals Up 15% in a Month: How to Play the Stock
- 1 month ago / fool.comVertex Pharmaceuticals: A Biotech Cash Cow With Pipeline Upside?
- 1 month ago / fool.comVertex Pharmaceuticals' Rally Has a New Engine -- and Wall Street Thinks the Best Is Still Ahead
Add to Watchlist
Select watchlists to add or remove VERX